TY - JOUR
T1 - Natural history of TANGO2 deficiency disorder
T2 - Baseline assessment of 73 patients
AU - Miyake, Christina Y.
AU - Lay, Erica J.
AU - Soler-Alfonso, Claudia
AU - Glinton, Kevin E.
AU - Houck, Kimberly M.
AU - Tosur, Mustafa
AU - Moran, Nancy E.
AU - Stephens, Sara B.
AU - Scaglia, Fernando
AU - Howard, Taylor S.
AU - Kim, Jeffrey J.
AU - Pham, Tam Dam
AU - Valdes, Santiago O.
AU - Li, Na
AU - Murali, Chaya N.
AU - Zhang, Lilei
AU - Kava, Maina
AU - Yim, Deane
AU - Beach, Cheyenne
AU - Webster, Gregory
AU - Liberman, Leonardo
AU - Janson, Christopher M.
AU - Kannankeril, Prince J.
AU - Baxter, Samantha
AU - Singer-Berk, Moriel
AU - Wood, Jordan
AU - Mackenzie, Samuel J.
AU - Sacher, Michael
AU - Ghaloul-Gonzalez, Lina
AU - Pedroza, Claudia
AU - Morris, Shaine A.
AU - Ehsan, Saad A.
AU - Azamian, Mahshid S.
AU - Lalani, Seema R.
N1 - Funding Information:
We thank all TANGO2 families who provided support and the TANGO2 Research Foundation, Chan Zuckerburg Initiative, and the Patient-Centered Outcomes Research Institute (PCORI) for support. We are grateful to Aarushi Nayak for assistance with figures. This study was funded by the TANGO2 Research Foundation and Chan Zuckerberg Initiative. C.Y.M. was supported by the American Heart Association Scientist Development Grant SDG 17SDG33410183 and National Institutes of Health (NIH) National Heart, Lung, and Blood Institute K23HL136932. L.Z. was supported by NIH HL143067, HL165270, and HL150589. S.J.M. was supported by NIH National Institute of Neurological Disorders and Stroke K12NS098482-06. S.R.L. was supported by NIH 1UG3TR004047-01. C.Y.M. L.Z. S.J.M. M.S. L.G.-G. and S.R.L. are supported by the TANGO2 Research Foundation. E.J.L. was supported by T32 GM07526-44. There are no relevant relationships with industry. Conceptualization: C.Y.M. S.R.L.; Data Curation: C.Y.M. E.J.L. C.S.-A. K.E.G. K.M.H. M.T. M.K. D.Y. C.B. G.W. L.L. C.M.J. P.J.K. S.A.E. M.S.A. S.R.L.; Formal Analysis: C.Y.M. C.S.-A. K.E.G. S.B.S. S.B. M.S. J.W. S.A.M.; Investigation: C.Y.M. E.J.L. C.S.-A. K.E.G. K.M.H. M.T. M.K. D.Y. C.B. G.W. L.L. C.M.J. P.J.K. S.A.E. M.S.A. S.R.L.; Methodology: C.Y.M. C.S.-A. K.E.G. S.B. M.S. J.W. C.P. S.A.M. S.R.L.; Project Administration: C.Y.M. M.S.A. S.R.L.; Supervision: C.Y.M. S.R.L.; Visualization: C.Y.M. E.J.L. C.S.-A. K.E.G. S.B.S. S.B. M.S.-B. J.W.; Writing-original draft: C.Y.M. E.J.L. C.S.-A. K.E.G. K.M.H. M.T. S.B.S. S.B. M.S. J.W. S.R.L.; Writing-review and editing: C.Y.M. E.J.L. C.S.-A. K.E.G. K.M.H. M.T. N.E.M. S.B.S. F.S. T.S.H. J.J.K. T.D.P. S.O.V. N.L. C.N.M. L.Z. M.K. D.Y. C.B. G.W. L.L. C.M.J. P.J.K. S.B. M.S.-B. J.W. S.J.M. M.S. L.G.-G. C.P. S.A.M. S.A.E. M.S.A. S.R.L. Patient clinical and genetic (de-identified and identifiable) data were obtained from multiple institutions and approved under a single Institutional Review Board (H-43240) of Baylor College of Medicine. Written consent was obtained from parents/legal guardians of participants.
Funding Information:
This study was funded by the TANGO2 Research Foundation and Chan Zuckerberg Initiative . C.Y.M. was supported by the American Heart Association Scientist Development Grant SDG 17SDG33410183 and National Institutes of Health (NIH) National Heart, Lung, and Blood Institute K23HL136932. L.Z. was supported by NIH HL143067, HL165270, and HL150589. S.J.M. was supported by NIH National Institute of Neurological Disorders and Stroke K12NS098482-06. S.R.L. was supported by NIH 1UG3TR004047-01. C.Y.M., L.Z., S.J.M., M.S., L.G.-G., and S.R.L. are supported by the TANGO2 Research Foundation . E.J.L. was supported by T32 GM07526-44. There are no relevant relationships with industry.
Publisher Copyright:
© 2022 American College of Medical Genetics and Genomics
PY - 2023/4
Y1 - 2023/4
N2 - Purpose: TANGO2 deficiency disorder (TDD), an autosomal recessive disease first reported in 2016, is characterized by neurodevelopmental delay, seizures, intermittent ataxia, hypothyroidism, and life-threatening metabolic and cardiac crises. The purpose of this study was to define the natural history of TDD. Methods: Data were collected from an ongoing natural history study of patients with TDD enrolled between February 2019 and May 2022. Data were obtained through phone or video based parent interviews and medical record review. Results: Data were collected from 73 patients (59% male) from 57 unrelated families living in 16 different countries. The median age of participants at the time of data collection was 9.0 years (interquartile range = 5.3-15.9 years, range = fetal to 31.8 years). A total of 24 different TANGO2 alleles were observed. Patients showed normal development in early infancy, with progressive delay in developmental milestones thereafter. Symptoms included ataxia, dystonia, and speech difficulties, typically starting between the ages of 1 to 3 years. A total of 46/71 (65%) patients suffered metabolic crises, and of those, 30 (65%) developed cardiac crises. Metabolic crises were significantly decreased after the initiation of B-complex or multivitamin supplementation. Conclusion: We provide the most comprehensive review of natural history of TDD and important observational data suggesting that B-complex or multivitamins may prevent metabolic crises.
AB - Purpose: TANGO2 deficiency disorder (TDD), an autosomal recessive disease first reported in 2016, is characterized by neurodevelopmental delay, seizures, intermittent ataxia, hypothyroidism, and life-threatening metabolic and cardiac crises. The purpose of this study was to define the natural history of TDD. Methods: Data were collected from an ongoing natural history study of patients with TDD enrolled between February 2019 and May 2022. Data were obtained through phone or video based parent interviews and medical record review. Results: Data were collected from 73 patients (59% male) from 57 unrelated families living in 16 different countries. The median age of participants at the time of data collection was 9.0 years (interquartile range = 5.3-15.9 years, range = fetal to 31.8 years). A total of 24 different TANGO2 alleles were observed. Patients showed normal development in early infancy, with progressive delay in developmental milestones thereafter. Symptoms included ataxia, dystonia, and speech difficulties, typically starting between the ages of 1 to 3 years. A total of 46/71 (65%) patients suffered metabolic crises, and of those, 30 (65%) developed cardiac crises. Metabolic crises were significantly decreased after the initiation of B-complex or multivitamin supplementation. Conclusion: We provide the most comprehensive review of natural history of TDD and important observational data suggesting that B-complex or multivitamins may prevent metabolic crises.
KW - Metabolic crises
KW - Natural history study
KW - TANGO2
KW - Treatment
KW - Vitamins
UR - http://www.scopus.com/inward/record.url?scp=85149678634&partnerID=8YFLogxK
U2 - 10.1016/j.gim.2022.11.020
DO - 10.1016/j.gim.2022.11.020
M3 - Article
C2 - 36473599
AN - SCOPUS:85149678634
SN - 1098-3600
VL - 25
JO - Genetics in Medicine
JF - Genetics in Medicine
IS - 4
M1 - 100352
ER -